title: Economic aspects of captopril treatment.
authors.forename: J
authors.initials: J
authors.lastname: Tsevat
authors.forename: M A
authors.initials: MA
authors.lastname: Pfeffer
authors.forename: L
authors.initials: L
authors.lastname: Goldman
authors.forename: T H
authors.initials: TH
authors.lastname: Lee
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D002216:Captopril / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000191:economics* / Q000401:mortality; D016019:Survival Analysis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril